This is, to the best of our knowledge, the first study to find a possible association between the ADRB3 rs4994 polymorphism and the development of NAFLD through an increase in BMI and insulin resistance. This evidence concerns the gene ADRB3 and metabolic dysfunction-associated steatotic liver disease.